Genedata Expressionist 5.2 with enhanced capabilities for Mass Spectrometry-based biomarker discovery will be demonstrated at the 57th ASMS Conference on Mass Spectrometry, May 31 - June 4, 2009, Booth# 133 at the Pennsylvania Convention Center.
Philadelphia, PA (PRWEB) June 1, 2009 -- Genedata, a leading provider of in silico solutions for pharmaceutical R&D and related life sciences, today announced the release of Expressionist 5.2 with enhanced capabilities for Mass Spectrometry (MS)-based biomarker discovery. Included in the Expressionist system are the advanced Refiner MS and Analyst modules, which process and analyze metabolomic and proteomic raw MS data and provide sophisticated statistical analysis capabilities for large volume data sets. Expressionist 5.2 will be demonstrated at the 57th ASMS Conference on Mass Spectrometry, May 31 - June 4, 2009, Booth 133 at the Pennsylvania Convention Center.
"Genedata's continued investment in Expressionist is invaluable and the new Expressionist system will drastically change the ways in which we are able to probe experimental systems," commented Professor James Mobley, director of the Comprehensive Cancer Center Proteomics Facility at the University of Alabama. "Expressionist enables us to better understand underlying biological mechanisms and the suppo
Copyright©2009 Vocus, Inc.
All rights reserved